Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sélim Aractingi

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Experimental Dermatology|October 8, 2016
Classifying skin diseases: Until where should we go?Sélim Aractingi
Presse Medicale (Paris, France : 1983)|November 7, 2006
[Sarcoidosis in tattoos in chronic hepatitis virus C]Nicolas Kluger, Sélim Aractingi
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 12, 2015
Skin disease in pregnancyBoutros Soutou, Sélim Aractingi
Annales De Medecine Interne|September 10, 2002
[Microchimerisme in systemic sclerosis]Sélim Aractingi, Stéphanie Regnier
Frontiers in Immunology|March 15, 2021
Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted TherapiesHélène Bugaut, Sélim Aractingi
Hematological Oncology|May 27, 2009
Myeloproliferative disorder therapy: assessment and management of adverse events--a dermatologist's perspectiveBoutros Soutou, Sélim Aractingi
Dermatology (Basel, Switzerland)|December 18, 2004
Microchimerism: fears and hopesSélim Aractingi, Kiarash Khosrotehrani
The British Journal of Dermatology|January 30, 2023
Correcting 'false' warnings with new tools? An illustrative exampleSélim Aractingi, Bénédicte Oulès
Dermatology (Basel, Switzerland)|April 2, 2004
Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcersLaure Méry, Robert Girot, Sélim Aractingi
Dermatology (Basel, Switzerland)|February 20, 2003
Sweet's syndrome and leukemia cutis: a common skin homing mechanism?Marie Dominique Vignon-Pennamen, Sélim Aractingi
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Experimental Dermatology|October 8, 2016
Classifying skin diseases: Until where should we go?Sélim Aractingi
Presse Medicale (Paris, France : 1983)|November 7, 2006
[Sarcoidosis in tattoos in chronic hepatitis virus C]Nicolas Kluger, Sélim Aractingi
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 12, 2015
Skin disease in pregnancyBoutros Soutou, Sélim Aractingi
Annales De Medecine Interne|September 10, 2002
[Microchimerisme in systemic sclerosis]Sélim Aractingi, Stéphanie Regnier
Frontiers in Immunology|March 15, 2021
Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted TherapiesHélène Bugaut, Sélim Aractingi
Hematological Oncology|May 27, 2009
Myeloproliferative disorder therapy: assessment and management of adverse events--a dermatologist's perspectiveBoutros Soutou, Sélim Aractingi
Dermatology (Basel, Switzerland)|December 18, 2004
Microchimerism: fears and hopesSélim Aractingi, Kiarash Khosrotehrani
The British Journal of Dermatology|January 30, 2023
Correcting 'false' warnings with new tools? An illustrative exampleSélim Aractingi, Bénédicte Oulès
Dermatology (Basel, Switzerland)|April 2, 2004
Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcersLaure Méry, Robert Girot, Sélim Aractingi
Dermatology (Basel, Switzerland)|February 20, 2003
Sweet's syndrome and leukemia cutis: a common skin homing mechanism?Marie Dominique Vignon-Pennamen, Sélim Aractingi
Pageof 6